HDR Gateway logo
HDR Gateway logo

Bookmarks

Development of ELISA and Rapid Testing Kits for COVID-19

Population Size

Not reported

Years

2021 - 2021

Associated BioSamples

None/not available

Geographic coverage

Pakistan

Lead time

Not applicable

Summary

This project aims to develop ELISA based detection kits for the detection of viral antigen of COVID-19, and separately to detect the immune response to COVID-19 infection. To be marketed in Pakistan.

Documentation

The electronic data will consist of documenting the different diagnostic reagents imported, with their technical details, specifications and expiry dates. A record will be kept of the use of these reagents, and their performance characteristics in the research laboratory. The second main data set will involve the development of the diagnostic kits, and documentation of all physical, chemical and immunological parameters around each diagnostic procedure, and the outcomes, and whether success or failure. The third set of data will be generated when the developed diagnostic kits are tested against the known samples received from the commercial (Metropole) laboratories and the results compared.
Dataset type
Health and disease
Dataset sub-type
Not applicable

Keywords

ELISA, COVID-19, Cost Effective, Diagnostics, Rapid Testing, SARS-CoV2

Observations

Observed Node
Disambiguating Description
Measured Value
Measured Property
Observation Date

Findings

Observations Not Applicable at this time (Oct 2021) and default values used where fields are mandatory

1

Count

30 Nov 2021

Provenance

Source of data extraction
Other
Collection source setting
Other
Patient pathway description
Human tissue samples collected from patients who attend routine diagnostic procedures at commercial laboratories and hospitals, especially for COVID related tests
Image contrast
Not stated
Biological sample availability
None/not available

Details

Publishing frequency
Static
Version
1.0.0
Modified

08/10/2024

Citation Requirements
RESPIRE Collaboration

Coverage

Start date

15/08/2021

End date

30/11/2021

Time lag
Not applicable
Geographic coverage
Pakistan
Maximum age range
150

Accessibility

Language
en
Controlled vocabulary
LOCAL
Format
CSV

Data Access Request

Dataset pipeline status
Not available
Time to dataset access
Not applicable
Access method category
Varies based on project
Access service description
Access is managed on a project-by-project basis. Contact the RESPIRE Collaboration.
Jurisdiction
PK
Data use limitation
No restriction
Data Controller
RESPIRE
Data Processor
RESPIRE

Dataset Types: Health and disease


Collection Sources: Other